Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Preventing sudden death with n-3 (omega-3) fatty acids and defibrillators.

Kottke TE, Wu LA, Brekke LN, Brekke MJ, White RD.

Am J Prev Med. 2006 Oct;31(4):316-323.

PMID:
16979456
2.

[Omega-3 fatty acids in cardiology. Latest developments].

von Schacky C.

MMW Fortschr Med. 2007 Sep 13;149 Suppl 3:97-101. Review. German.

PMID:
17955786
3.

Antiarrhythmic effects of n-3 fatty acids: evidence from human studies.

Geelen A, Brouwer IA, Zock PL, Katan MB.

Curr Opin Lipidol. 2004 Feb;15(1):25-30. Review.

PMID:
15166805
4.

Implantable cardioverter defibrillators for prevention of sudden cardiac death.

Sukhija R, Mehta V, Leonardi M, Mehta JL.

Clin Cardiol. 2007 Jan;30(1):3-8. Review.

5.

Secondary prevention of coronary artery disease with omega-3 fatty acids.

Jacobson TA.

Am J Cardiol. 2006 Aug 21;98(4A):61i-70i. Epub 2006 May 30. Review.

PMID:
16919518
6.

n-3 fatty acids and the risk of sudden cardiac death.

Christensen JH, Schmidt EB.

Lipids. 2001;36 Suppl:S115-8. Review.

PMID:
11837984
7.
8.

Implantable cardioverter-defibrillators should be used routinely in the elderly.

Buxton AE.

Am J Geriatr Cardiol. 2006 Nov-Dec;15(6):361-4; quiz 365-6. Review.

PMID:
17086029
9.

Cardiovascular benefits of omega-3 fatty acids.

von Schacky C, Harris WS.

Cardiovasc Res. 2007 Jan 15;73(2):310-5. Epub 2006 Sep 1. Review.

PMID:
16979604
10.

Omega-3 consumption and sudden cardiac death in schizophrenia.

Scorza FA, Cysneiros RM, Terra VC, Scorza CA, Cavalheiro EA, Ribeiro MO, Gattaz WF.

Prostaglandins Leukot Essent Fatty Acids. 2009 Oct;81(4):241-5. doi: 10.1016/j.plefa.2009.06.008. Epub 2009 Jul 22. Review.

PMID:
19628381
11.

Effects of lipid-altering therapies on ventricular arrhythmias and sudden cardiac death.

Majmudar MD, Tompkins C, Bachmann JM, Blumenthal RS, Marine JE.

Cardiol Rev. 2009 Mar-Apr;17(2):60-9. doi: 10.1097/CRD.0b013e3181861be8. Review.

PMID:
19367147
12.

Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both?

von Schacky C.

Curr Opin Clin Nutr Metab Care. 2008 Mar;11(2):94-9. doi: 10.1097/MCO.0b013e3282f44bdf. Review.

PMID:
18301082
13.

Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.

Leaf A.

J Cardiovasc Med (Hagerstown). 2007 Sep;8 Suppl 1:S27-9. Review.

PMID:
17876194
14.

Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: a systematic review and economic evaluation.

Bryant J, Brodin H, Loveman E, Clegg A.

Int J Technol Assess Health Care. 2007 Winter;23(1):63-70. Review.

PMID:
17234018
15.

Global public health problem of sudden cardiac death.

Mehra R.

J Electrocardiol. 2007 Nov-Dec;40(6 Suppl):S118-22. Review.

PMID:
17993308
16.

Cardiovascular disease prevention and treatment.

von Schacky C.

Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):193-8. doi: 10.1016/j.plefa.2009.05.009. Epub 2009 Jun 10. Review.

PMID:
19520557
17.

Fish oil fatty acids as cardiovascular drugs.

Leaf A, Kang JX, Xiao YF.

Curr Vasc Pharmacol. 2008 Jan;6(1):1-12. Review.

PMID:
18220934
18.

Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction.

Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA.

Ann Intern Med. 2007 Aug 21;147(4):251-62. Review.

PMID:
17709759
19.

Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.

Leaf A.

Fundam Clin Pharmacol. 2006 Dec;20(6):525-38. Review.

PMID:
17109646
20.

The other side of the coin: Beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy.

Scorza FA, Cysneiros RM, Arida RM, Terra-Bustamante VC, de Albuquerque M, Cavalheiro EA.

Epilepsy Behav. 2008 Aug;13(2):279-83. doi: 10.1016/j.yebeh.2008.04.011. Epub 2008 Jun 3. Review.

PMID:
18511348

Supplemental Content

Support Center